ES402176A1 - Un procedimiento para preparar un complejo de sal de insu- lina y protamina. - Google Patents

Un procedimiento para preparar un complejo de sal de insu- lina y protamina.

Info

Publication number
ES402176A1
ES402176A1 ES402176A ES402176A ES402176A1 ES 402176 A1 ES402176 A1 ES 402176A1 ES 402176 A ES402176 A ES 402176A ES 402176 A ES402176 A ES 402176A ES 402176 A1 ES402176 A1 ES 402176A1
Authority
ES
Spain
Prior art keywords
insulin
protamine
salt
insulin product
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES402176A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES402176A1 publication Critical patent/ES402176A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES402176A 1971-04-30 1972-04-27 Un procedimiento para preparar un complejo de sal de insu- lina y protamina. Expired ES402176A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13912071A 1971-04-30 1971-04-30

Publications (1)

Publication Number Publication Date
ES402176A1 true ES402176A1 (es) 1975-03-01

Family

ID=22485216

Family Applications (1)

Application Number Title Priority Date Filing Date
ES402176A Expired ES402176A1 (es) 1971-04-30 1972-04-27 Un procedimiento para preparar un complejo de sal de insu- lina y protamina.

Country Status (23)

Country Link
US (1) US3758683A (enExample)
JP (1) JPS5735185B1 (enExample)
BE (1) BE782651A (enExample)
CA (1) CA976085A (enExample)
CH (1) CH566784A5 (enExample)
CS (1) CS209458B2 (enExample)
DD (1) DD100708A5 (enExample)
DE (1) DE2219635C3 (enExample)
DK (1) DK131760C (enExample)
ES (1) ES402176A1 (enExample)
FI (1) FI49773C (enExample)
FR (1) FR2134658B1 (enExample)
GB (1) GB1385086A (enExample)
HU (1) HU166989B (enExample)
IL (1) IL39181A (enExample)
NL (1) NL178258C (enExample)
NO (1) NO137178C (enExample)
PL (1) PL86966B1 (enExample)
RO (1) RO64387A (enExample)
SE (1) SE378066B (enExample)
SU (1) SU508162A3 (enExample)
YU (1) YU36155B (enExample)
ZA (1) ZA722243B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK140801B (da) * 1975-01-15 1979-11-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.
NL193099C (nl) * 1981-10-30 1998-11-03 Novo Industri As Gestabiliseerde insuline-oplossing.
FI882921L (fi) * 1986-10-20 1988-06-17 Novo Industri As Protaminzink-insulinpreparat.
CA1339416C (en) * 1987-02-25 1997-09-02 Liselotte Langkjaer Insulin derivatives
DE19726167B4 (de) * 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
US6624141B1 (en) 1999-03-17 2003-09-23 The Regents Of The University Of Michigan Protamine fragment compositions and methods of use
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
HUE068164T2 (hu) 2008-10-17 2024-12-28 Sanofi Aventis Deutschland Egy inzulin és egy GLP-1 agonista kombinációja
SG10201500871TA (en) 2009-11-13 2015-04-29 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
CA2780460C (en) 2009-11-13 2018-09-04 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine
RS55378B1 (sr) 2010-08-30 2017-03-31 Sanofi Aventis Deutschland Upotreba ave0010 za proizvodnju leka za tretman diabetes mellitus tipa 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
BR112014004726A2 (pt) 2011-08-29 2017-04-04 Sanofi Aventis Deutschland combinação farmacêutica para uso no controle glicêmico em pacientes de diabetes tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
TWI758239B (zh) 2014-12-12 2022-03-21 德商賽諾菲阿凡提斯德意志有限公司 甘精胰島素/利司那肽固定比率配製劑
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
EP3474820B1 (en) 2017-08-24 2024-02-07 Novo Nordisk A/S Glp-1 compositions and uses thereof
PE20230819A1 (es) 2020-02-18 2023-05-19 Novo Nordisk As Composiciones y usos de glp-1
CN118949061A (zh) * 2023-08-07 2024-11-15 浙江大学 一种糖响应鱼精蛋白胰岛素及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5038E (fr) * 1904-03-09 1905-12-02 Georges Frederic Brade Perfectionnements dans la fabrication des organes du métronome
GB889769A (en) * 1957-07-18 1962-02-21 Nordisk Insulinlab Slowly acting insulin preparation in crystalline form

Also Published As

Publication number Publication date
IL39181A0 (en) 1972-06-28
FI49773C (fi) 1975-10-10
YU36155B (en) 1982-02-25
DD100708A5 (enExample) 1973-10-05
CH566784A5 (enExample) 1975-09-30
NL178258B (nl) 1985-09-16
RO64387A (fr) 1979-07-15
JPS5735185B1 (enExample) 1982-07-27
US3758683A (en) 1973-09-11
CS209458B2 (en) 1981-12-31
NO137178C (no) 1978-01-18
DE2219635B2 (de) 1980-11-27
YU114272A (en) 1981-06-30
IL39181A (en) 1974-09-10
GB1385086A (en) 1975-02-26
FR2134658A1 (enExample) 1972-12-08
NL7205865A (enExample) 1972-11-01
BE782651A (fr) 1972-10-26
DK131760C (da) 1976-02-02
FR2134658B1 (enExample) 1975-10-17
CA976085A (en) 1975-10-14
NO137178B (no) 1977-10-10
SE378066B (enExample) 1975-08-18
PL86966B1 (enExample) 1976-06-30
ZA722243B (en) 1973-11-28
FI49773B (enExample) 1975-06-30
DK131760B (da) 1975-09-01
HU166989B (enExample) 1975-07-28
DE2219635C3 (de) 1981-10-15
NL178258C (nl) 1986-02-17
SU508162A3 (ru) 1976-03-25
DE2219635A1 (de) 1972-11-09

Similar Documents

Publication Publication Date Title
ES402176A1 (es) Un procedimiento para preparar un complejo de sal de insu- lina y protamina.
ES414862A1 (es) Un procedimiento para la preparacion de una composicion a- limenticia.
ES391016A1 (es) Un procedimiento de preparacion de un polinucleotido de fi-lamentos multiples.
GB1361577A (en) Diagnostic composition
ES395254A1 (es) Un metodo para la preparacion de una composicion laxante - antiacida, liquida, transparente.
ES391855A1 (es) Un procedimiento para la preparacion de una sal de aluminiode n-acetil-l-glutamina.
ES404001A1 (es) Procedimiento para la obtencion de compelejos de dos compo-nentes.
GB1382008A (en) Fungicidal and/or bacterial composition and method
ES396028A1 (es) Procedimiento de obtencion de palmitato de fluracepan.
GB753269A (en) Improvements in or relating to antibiotic compositions
ES268449A1 (es) Proceso para la preparaciën de un miembro del grupo consistente en una sal de pamoato acido de furaltadona y un hidrato de la misma
ES386714A1 (es) Procedimiento para la preparacion de nuevos derivados de tiepina.
ES416813A1 (es) Procedimiento para estabilizar y precipitar soluciones acuosas concentradas de proteasa.
GB1383292A (en) Process for preparing 1,3,4-thiadiazole-2-thiol compounds
GB1221574A (en) New iron oxide complexes
ES289667A1 (es) Procedimiento de preparaciën de sulfametoxipiridazina-fenilpropanoldisulfonato sëdico
ES405154A3 (es) Procedimiento para la obtencion de acido 3, 4, 5 trimetoxi-benzoilamidocarboxilico y sus sales.
GB1326422A (en) Film cartridges
ES359464A1 (es) Mejoras introducidas en el procedimiento de preparacion de la sal de diamonio de acido etilen-bis-ditiocarbamico.
GB1230298A (enExample)
GB1204293A (en) Ammonium salt complexes of, and process for purifying, hexachlorophene and 2,4,5-trichlorophenol
ES377609A1 (es) Procedimiento para la preparacion de compuestos de orotato-glicinato de magnesio.
ES305681A1 (es) Un procedimiento para preparar una sal doble
CA839269A (en) Metal complexes of 4-amino-2,2,6,6-tetramethyl-1-oxyl-piperidine-4-carboxylic acid
ES298908A1 (es) Procedimiento de fabricacion de un producto antivirotico para combatir los virus

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19880525